Obatoclax has been used in trials studying the treatment of AML, Leukemia, Myelofibrosis, Hodgkin's Lymphoma, and Mantle-Cell Lymphoma, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.